| Somatuline Autogel 120mg, solution for injection in a pre-filled syringe PA0869/004/004 |
Lanreotide acetate |
Ipsen Pharmaceuticals Limited |
Marketed |
| Somatuline Autogel 60 mg, solution for injection in a prefilled syringe PA0869/004/002 |
Lanreotide acetate |
Ipsen Pharmaceuticals Limited |
Marketed |
| Somatuline Autogel 90mg, solution for injection in a pre-filled syringe PA0869/004/003 |
Lanreotide acetate |
Ipsen Pharmaceuticals Limited |
Marketed |
| Somavert EU/1/02/240/1-3 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |
| Somavert 25 mg powder and solvent for solution for injection EU/1/02/240/009-010 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |
| Somavert 30 mg powder and solvent for solution for injection EU/1/02/240/011-012 |
Pegvisomant |
Pfizer Europe MA EEIG |
— |
| Sondelbay EU/1/22/1628/001-002 |
Teriparatide |
Accord Healthcare S.L.U. |
— |
| SonoVue 8 microlitres/mL powder and solvent for dispersion for injection EU/1/01/177/002 |
Sulphur hexafluoride |
Bracco International B.V. |
— |
| Sorafenib Accord 200 mg film-coated tablets EU/1/22/1696/001 |
Sorafenib Tosilate |
Accord Healthcare S.L.U. |
— |
| SOTYKTU 6 mg Film-coated tablet EU/1/23/1718/001-008 |
Deucravacitinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sovaldi 150 mg coated granules in sachet EU/1/13/894/004 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Sovaldi 200 mg coated granules in sachet EU/1/13/894/005 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Sovaldi 200 mg film-coated tablets EU/1/13/894/003 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Sovaldi 400 mg film-coated tablets EU/1/13/894/001-002 |
Sofosbuvir |
Gilead Sciences Ireland UC |
— |
| Spectrila 10,000 U powder for concentrate for solution for infusion EU/1/15/1072/001-002 |
Recombinant l-asparaginase |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Spedra 100 mg tablets EU/1/13/841/004-007 |
Avanafil |
Menarini International Operations Luxembourg S.A. |
— |
| Spedra 200 mg tablets EU/1/13/841/008-010 |
Avanafil |
Menarini International Operations Luxembourg S.A. |
— |
| Spedra 50 mg tablets EU/1/13/841/001-003 |
Avanafil |
Menarini International Operations Luxembourg S.A. |
— |
| Spevigo 150 mg solution for injection in pre-filled syringe EU/1/22/1688/002 |
Spesolimab |
LEO Pharma A/S |
— |
| Spevigo 300 mg solution for injection in pre-filled syringe EU/1/22/1688/003 |
Spesolimab |
LEO Pharma A/S |
— |
| Spevigo 450 mg concentrate for solution for infusion EU/1/22/1688/001 |
Spesolimab |
LEO Pharma A/S |
— |
| Spexotras 0.05 mg/ml powder for oral solution EU/1/23/1781/001 |
Trametinib dimethyl sulfoxide |
Novartis Europharm Limited |
— |
| Spherox 10-70 spheroids/ cm2 implantation suspension EU/1/17/1181/001-002 |
Spheroids of human autologous matrix-associated chondrocytes |
Rejuvenate GmbH |
— |
| Spikevax 0.1 mg/mL dispersion for injection EU/1/20/1507/002 |
Elasomeran |
Moderna Biotech Spain S.L. |
— |
| Spikevax 0.2 mg/mL dispersion for injection EU/1/20/1507/001 |
mRNA-1273 |
MODERNA BIOTECH SPAIN, S.L (Non-Current) |
— |
| Spikevax 50 micrograms dispersion for injection in pre-filled syringe EU/1/20/1507/003 |
Elasomeran |
Moderna Biotech Spain S.L. |
— |
| Spikevax bivalent Original/Omicron BA.1 EU/1/20/1507/004-005 |
Elasomeran |
Moderna Biotech Spain S.L. |
— |
| Spikevax bivalent Original/Omicron BA.1 EU/1/20/1507/007-008 |
Elasomeran |
Moderna Biotech Spain S.L. |
— |
| Spikevax bivalent Original/Omicron BA4-5 EU/1/20/1507/006 |
Elasomeran |
Moderna Biotech Spain S.L. |
— |
| Spikevax XBB.1.5 25 micrograms dispersion for injection in pre-filled syringe. COVID-19 mRNA Vaccine EU/1/20/1507/027-030 |
Andusomeran |
Moderna Biotech Spain S.L. |
— |
| Spinraza 12 mg solution for injection EU/1/17/1188/001 |
Nusinersen |
Biogen Netherlands B.V. |
— |
| Spiriva 18 microgram inhalation powder, hard capsule PPA23080/007/001 |
Tiotropium bromide |
Merit Pharmaceuticals Limited |
— |
| Spravato 28 mg nasal spray, solution EU/1/19/1410/001-004 |
ESKETAMINE HYDROCHLORIDE, Esketamine |
Janssen-Cilag International NV |
— |
| Sprycel 10 mg/mL powder for oral suspension EU/1/06/363/016 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 100 mg film-coated tablets EU/1/06/363/010-11 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 140 mg film-coated tablets EU/1/06/363/014-015 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 20 mg film-coated tablets EU/1/06/363/1-4-7 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 50 mg film-coated tablet EU/1/06/363/2-5-8 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 70 mg film-coated tablets EU/1/06/363/3-6-9 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Sprycel 80 mg film-coated tablets EU/1/06/363/012-013 |
Dasatinib |
Bristol-Myers Squibb Pharma EEIG |
— |
| Stagliptin Accord 100 mg film-coated tablets EU/1/22/1633/011-015 |
Sitagliptin Hydrochloride Monohydrate |
Accord Healthcare S.L.U. |
— |
| Stagliptin Accord 25 mg film-coated tablets EU/1/22/1633/001-005 |
Sitagliptin Hydrochloride Monohydrate |
Accord Healthcare S.L.U. |
— |
| Stagliptin Accord 50 mg film-coated tablets EU/1/22/1633/006-010 |
Sitagliptin Hydrochloride Monohydrate |
Accord Healthcare S.L.U. |
— |
| Stalevo EU/1/03/260/001-004,13,16 |
Carbidopa, Entacapone, Levodopa |
Orion Corporation |
— |
| Stalevo EU/1/03/260/005-008,14,17 |
|
Orion Corporation |
— |
| Stalevo EU/1/03/260/009-012,15,18 |
|
Orion Corporation |
— |
| Stalevo 125 mg/31.25 mg/200 mg film-coated tablets EU/1/03/260/29-33 |
Carbidopa monohydrate, Entacapone, Levodopa |
Orion Corporation |
— |
| Stalevo 175 mg/43.75 mg/200 mg film-coated tablets EU/1/03/260/034-038 |
Carbidopa, Entacapone, Levodopa |
Orion Corporation |
— |
| Stalevo 200 mg/50 mg/200 mg film-coated tablets EU/1/03/260/19-23 |
Carbidopa, Entacapone, Levodopa |
Orion Corporation |
— |
| Stalevo 75 mg/18.75 mg/200 mg film-coated tablets EU/1/03/260/24-28 |
Carbidopa monohydrate, Levodopa, Entacapone |
Orion Corporation |
— |